GlycanAge

📍 Newcastle upon Tyne, United Kingdom👥 45 employees💰 Last funded Sep 2024
At GlycanAge, we’re redefining the way we understand and measure aging. Backed by over 30 years of research and more than 300 peer-reviewed publications, our work centers on glycans—complex molecules that regulate inflammation and immune system function. These biomarkers offer a unique lens into your biological age, helping us understand how lifestyle, chronic inflammation, and environmental factors influence the aging process. Our flagship product, the GlycanAge® test, is a simple at-home test that goes beyond genetics to show how your body is actually aging—right now. Its already used by over 1,500 providers and tens of thousands of customers globally to track the impact of interventions and optimise preventative care strategies. Whether youre leading in the longevity space or taking the first step in your health journey, GlycanAge empowers you with actionable insights to live healthier for longer.
5
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography3 countries
Bulgaria
2
Indonesia
1
United States
1
Investor activity2022–2024 · investors recorded per year
2022320242
Recent (last 2y)Earlier
Frequently asked questions
Who invested in GlycanAge?
GlycanAge has 5 investors on record on gritt.io.
When did GlycanAge last raise funding?
The most recent investment in GlycanAge recorded on gritt.io was in September 2024.
What industry is GlycanAge in?
GlycanAge operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is GlycanAge based?
GlycanAge is headquartered in Newcastle upon Tyne, United Kingdom.